Serge Adnot
About
Serge Adnot is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology.
According to data from OpenAlex, Serge Adnot has authored 215 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Pulmonary and Respiratory Medicine, 84 papers in Physiology and 40 papers in Molecular Biology. Recurrent topics in Serge Adnot's work include Pulmonary Hypertension Research and Treatments (98 papers), Nitric Oxide and Endothelin Effects (44 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (23 papers). Serge Adnot is often cited by papers focused on Pulmonary Hypertension Research and Treatments (98 papers), Nitric Oxide and Endothelin Effects (44 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (23 papers). Serge Adnot collaborates with scholars based in France, United States and Germany. Serge Adnot's co-authors include Saadia Eddahibi, Bernadette Raffestin, M. Hamon, Marc Humbert, Élie Fadel, Gérald Simonneau, Bernard Maître, Élisabeth Marcos, Philippe Dartevelle and Ly Tu and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.
In The Last Decade
Serge Adnot
210 papers receiving 12.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Serge Adnot France | 65 | 8.0k | 3.7k | 2.9k | 2.8k | 1.5k | 215 | 12.4k | ||
| Saadia Eddahibi France | 54 | 6.8k 0.9× | 3.3k 0.9× | 1.9k 0.7× | 1.8k 0.6× | 1.2k 0.8× | 128 | 8.9k | ||
| Jason X.‐J. Yuan United States | 60 | 5.9k 0.7× | 2.9k 0.8× | 5.5k 1.9× | 2.1k 0.8× | 1.5k 1.0× | 199 | 11.8k | ||
| Ε. Kenneth Weir United States | 54 | 5.9k 0.7× | 3.6k 1.0× | 3.9k 1.4× | 3.6k 1.3× | 978 0.6× | 175 | 11.6k | ||
| Ralph T. Schermuly Germany | 72 | 13.8k 1.7× | 6.2k 1.7× | 5.8k 2.0× | 3.2k 1.1× | 2.3k 1.5× | 397 | 20.0k | ||
| Paul M. Hassoun United States | 64 | 11.6k 1.4× | 6.7k 1.8× | 2.6k 0.9× | 1.5k 0.5× | 1.9k 1.2× | 279 | 16.0k | ||
| Ivan F. McMurtry United States | 61 | 7.1k 0.9× | 3.3k 0.9× | 3.2k 1.1× | 4.9k 1.7× | 1.6k 1.0× | 204 | 12.3k | ||
| Sébastien Bonnet Canada | 60 | 7.2k 0.9× | 3.3k 0.9× | 5.0k 1.7× | 1.1k 0.4× | 1.3k 0.9× | 192 | 11.6k | ||
| Adel Giaid Canada | 47 | 3.8k 0.5× | 3.4k 0.9× | 2.3k 0.8× | 4.1k 1.5× | 2.9k 1.9× | 115 | 11.2k | ||
| Nicholas W. Morrell United Kingdom | 74 | 15.1k 1.9× | 6.2k 1.7× | 6.0k 2.1× | 1.8k 0.6× | 2.4k 1.6× | 330 | 20.6k | ||
| Florent Soubrier France | 60 | 3.9k 0.5× | 9.6k 2.6× | 3.6k 1.3× | 1.4k 0.5× | 1.9k 1.2× | 194 | 17.2k |
Countries citing papers authored by Serge Adnot
Since
Specialization
Citations
This map shows the geographic impact of Serge Adnot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serge Adnot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serge Adnot more than expected).
Fields of papers citing papers by Serge Adnot
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Serge Adnot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serge Adnot. The network helps show where Serge Adnot may publish in the future.
Co-authorship network of co-authors of Serge Adnot
This figure shows the co-authorship network connecting the top 25 collaborators of Serge Adnot. A scholar is included among the top collaborators of Serge Adnot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serge Adnot. Serge Adnot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ranchoux, Benoît, Fabrice Antigny, Catherine Rücker‐Martin, et al.. (2015). Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension. Circulation. 131(11). 1006–1018.
2.
Mouraret, Nathalie, Élisabeth Marcos, Shariq Abid, et al.. (2013). Activation of Lung p53 by Nutlin-3a Prevents and Reverses Experimental Pulmonary Hypertension. Circulation. 127(16). 1664–1676.
3.
Dagouassat, Maylis, Jean‐Marie Gagliolo, M Bourin, et al.. (2013). The Cyclooxygenase-2–Prostaglandin E2 Pathway Maintains Senescence of Chronic Obstructive Pulmonary Disease Fibroblasts. American Journal of Respiratory and Critical Care Medicine. 187(7). 703–714.
4.
Houssaïni, Amal, Shariq Abid, Nathalie Mouraret, et al.. (2013). Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 48(5). 568–577.
5.
Damy, Thibaud, Laurent Margarit, Diane Bodez, et al.. (2012). Prognostic Impact of Sleep-Disordered Breathing and its Treatment with Nocturnal Ventilation for Chronic Heart Failure. European Journal of Heart Failure. 14(9). 1009–1019.
6.
Gary‐Bobo, Guillaume, Marco Alifano, Élisabeth Marcos, et al.. (2011). Pulmonary Artery Smooth Muscle Cell Senescence Is a Pathogenic Mechanism for Pulmonary Hypertension in Chronic Lung Disease. Circulation Research. 109(5). 543–553.
7.
Dessap, Armand Mekontso, Jean‐François Deux, Nour Abidi, et al.. (2011). Pulmonary Artery Thrombosis during Acute Chest Syndrome in Sickle Cell Disease. American Journal of Respiratory and Critical Care Medicine. 184(9). 1022–1029.
8.
Amsellem, Valérie, Guillaume Gary‐Bobo, Élisabeth Marcos, et al.. (2011). Telomere Dysfunction Causes Sustained Inflammation in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 184(12). 1358–1366.
9.
Dessap, Armand Mekontso, Guillaume Voiriot, Tong Zhou, et al.. (2011). Conflicting Physiological and Genomic Cardiopulmonary Effects of Recruitment Maneuvers in Murine Acute Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 46(4). 541–550.
10.
Guilluy, Christophe, Saadia Eddahibi, C. Agard, et al.. (2009). RhoA and Rho Kinase Activation in Human Pulmonary Hypertension: Role of 5-HT Signaling. American Journal of Respiratory and Critical Care Medicine. 179(12). 1151–1158.
11.
Savale, Laurent, Ari Chaouat, Sylvie Bastuji‐Garin, et al.. (2009). Shortened Telomeres in Circulating Leukocytes of Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 179(7). 566–571.
12.
Dessap, Armand Mekontso, Leon Rusel, Anoosha Habibi, et al.. (2008). Pulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease. American Journal of Respiratory and Critical Care Medicine. 177(6). 646–653.
13.
Sanchez, Olivier, Élisabeth Marcos, Frédéric Perros, et al.. (2007). Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 176(10). 1041–1047.
14.
Eddahibi, Saadia, Christophe Guignabert, Anne‐Marie Barlier‐Mur, et al.. (2006). Cross Talk Between Endothelial and Smooth Muscle Cells in Pulmonary Hypertension. Circulation. 113(15). 1857–1864.
15.
Dewachter, Laurence, Serge Adnot, Élie Fadel, et al.. (2006). Angiopoietin/Tie2 Pathway Influences Smooth Muscle Hyperplasia in Idiopathic Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 174(9). 1025–1033.
16.
Brégeon, Fabienne, Laurent Papazian, Florian Lange, et al.. (2005). Decreased VEGF concentration in lung tissue and vascular injury during ARDS. European Respiratory Journal. 25(1). 139–146.
17.
Eddahibi, Saadia, Marc Humbert, Saı̈d Sediame, et al.. (2000). Imbalance between Platelet Vascular Endothelial Growth Factor and Platelet-derived Growth Factor in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 162(4). 1493–1499.
18.
MacLean, Margaret R., Philippe Hervé, Saadia Eddahibi, & Serge Adnot. (2000). 5‐hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. British Journal of Pharmacology. 131(2). 161–168.
19.
Teíger, Emmanuel, et al.. (1998). Polycythemia Impairs Vasodilator Response to Acetylcholine in Patients with Chronic Hypoxemic Lung Disease. American Journal of Respiratory and Critical Care Medicine. 157(5). 1452–1460.
20.
Eddahibi, Saadia, et al.. (1998). Effect of Dexfenfluramine Treatment in Rats Exposed to Acute and Chronic Hypoxia. American Journal of Respiratory and Critical Care Medicine. 157(4). 1111–1119.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Saadia Eddahibi Breakdown of academic impact, for papers by Jason X.‐J. Yuan Breakdown of academic impact, for papers by Ε. Kenneth Weir Breakdown of academic impact, for papers by Ralph T. Schermuly Breakdown of academic impact, for papers by Paul M. Hassoun Breakdown of academic impact, for papers by Ivan F. McMurtry Breakdown of academic impact, for papers by Sébastien Bonnet Breakdown of academic impact, for papers by Adel Giaid Breakdown of academic impact, for papers by Nicholas W. Morrell Breakdown of academic impact, for papers by Florent Soubrier